Silencing of genes coding for transcription factors: Biological effects of decoy oligonucleotides on cystic fibrosis bronchial epithelial cells

Minerva Biotecnologica

Volumn 20, Issue 2, 2008, Pages 79-83

  Borgatti, M ^a   Bezzerri, V ^b   Mancini, I ^a   Nicolis, E ^b   Dechecchi, M C ^b   Rizzotti, P ^b   Lampronti, I ^a   Gambari, R ^a   Cabrini, G ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Chemokines; Cystic fibrosis; Cytokines; Inflammation; Transcription factors

Indexed keywords

CHEMOKINE; DECOY OLIGONUCLEOTIDE; DOUBLE STRANDED DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN DECOY OLIGONUCLEOTIDE; INTERLEUKIN 6; INTERLEUKIN 8; OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP1 DECOY OLIGONUCLEOTIDE;

BINDING AFFINITY; BRONCHUS MUCOSA; CONFERENCE PAPER; CONSENSUS SEQUENCE; CONTROLLED STUDY; CYSTIC FIBROSIS; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN BINDING; PSEUDOMONAS AERUGINOSA; REGULATORY SEQUENCE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

PSEUDOMONAS AERUGINOSA;

EID: 49149092181     PISSN: 11204826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. Boucher RC. New concepts of the pathogenesis of cystic fibrosis lung disease, Eur Respir J 2004;23:146-58.
2. Verkman AS, Song Y, Thiagarajah JR. Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease. Am J Physiol Cell Physiol 2003;284:C2-15.
3. Machen TE. Innate immune response in CF airway epithelia: hyperinflammatory? Am J Physiol Cell Physiol 2006;291:C218-C30.
4. Puchelle E, De Bentzmann S, Hubeau C, Jacquot J, Gaillard D. Mechanisms involved in cystic fibrosis airway inflammation. Pediatr Pulmonol Suppl 2001;23:143-5.
5. Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghaim H et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995;152:2111-8.
6. Jones AM, Martin L, Bright-Thomas RJ, Dodd ME, McDowell A, Moffitt KL et al. Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeraginosa. Eur Respir J 2003;22:503-6.
7. Becker MN, Sauer MS, Muhlebach MS, Hirsh AJ, Wu Q, Verghese MW et al. Cytokine secretion by cystic fibrosis airway epithelial cells. Am J Respir Crit Care Med 2004;169:645-53.
8. Koehler DR, Downey GP, Sweezey NB, Tanswell AK, Hu J. Lung inflammation as a therapeutic target in cystic fibrosis. Am J Respir Cell Mol Biol 2004;31:377-81.
9. Bezzerri V, Borgatti M, Nicolis E, Lampronti I, Dechecchi MC, Mancini I et al. Transcription Factor Oligodeoxynucleotides to NF-[kappa]B Inhibit Transcription of IL-8 in Bronchial Cells. Am J Respir Cell Mol Biol 2008 [Epub ahead of print].
10. Escotte S, Tabary O, Dusser D, Majer-Teboul C, Puchelle E, Jacquot J. Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-beta kinase pathway. Eur Respir J 2003;21:574-81.
11. Borgatti M, Bezzerri V, Mancini I, Nicolis E, Dechecchi MC, Lampronti I et al. Induction of IL-6 gene expression in a CF bronchial epithelial cell line by Pseudomonas aeruginosa is dependent on transcription factors belonging to the Sp1 superfamily. Biochem Biophys Res Commun 2007;357:977-83.
12. Mann MJ. Transcription factor decoys: a new model for disease intervention. Ann NY Acad Sci 2005;1058:128-39.
13. Mann MJ, Dzau VJ. Therapeutic applications of transcription factor decoy oligonucleotides. J Clin Invest 2000;106:1071-5.
14. Mischiati C, Borgatti M, Bianchi N, Rutigliano C, Tomassetti M, Feriotto G et al. Interaction of the human NF-kappaB p52 transcription factor with DNA-PNA hybrids mimicking the NF-kappaB binding sites of the human immunodeficiency virus type 1 promoter. J Biol Chem 1999;274:33114-22.
15. Penolazzi L, Borgatti M, Lambertini E, Mischiati C, Finotti A, Romanelli A et al. Peptide nucleic acid-DNA decoy chimeras targeting NF-kappaB transcription factors: Induction of apoptosis in human primary osteoclasts. Int J Mol Med 2004;14:145-52.
16. Penolazzi L, Lambertini E, Borgatti M, Piva R, Cozzani M, Giovannini I et al. Decoy oligodeoxynucleotides targeting NF-kappaB transcription factors: induction of apoptosis in human primary osteoclasts. Biochem Pharmacol 2003;66:1189-98.
17. Cooper JA Jr, Parks JM, Carcelen R, Kahlon SS, Sheffield M, Culbreth R. Attenuation of interleukin-8 production by inhibiting nuclear factor-kappaB translocation using decoy oligonucleotides. Biochem Pharmacol 2000;59:605-13.
18. Griesenbach U, Scheid P, Hillery E, de Martin R, Huang L, Geddes DM et al.. Anti-inflammatory gene therapy directed at the airway epithelium. Gene Ther 2000;7:306-13.
19. Griesenbach U, Cassady RL, Cain RJ, MduBois RM, Geddes DM, Alton EW. Cytoplasmic deposition of NFkappaB decoy oligonucleotides is insufficient to inhibit bleomycin-induced pulmonary inflammation. Gene Ther 2002;9:1109-15.
20. Lambertini E, Penolazzi L, Tavanti E, Pocaterra B, Schincaglia GP, Torreggiani E et al. Modulation of expression of specific transcription factors involved in the bone microenvironment. Minerva Biotec 2008;20:69-77.
21. Bianchi N, Borgatti M, Gambari R. Gene silencing in thalassemia. Minerva Biotec 2008;20:51-5.
22. Zeitlin PL, Lu L, Rhim J, Cutting GR, Stetten G, Kieffer R et al. Cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. Am J Respir Cell Mol Biol 1991;4:313-9.
23. Holloway BW. Genetic recombination in Pseudomonas aeruginosa. J Gen Microbiol 1955;13:572-81.
24. Roebuck KA, Finnegan A. Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J Leukoc Biol 1999;66:876-88.
25. Sanceau J, Kaisho T, Hirano T, Wietzerbin J. Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1, NF kappa B, and Sp1 transcription factors. J Biol Chem 1995;270:27920-31.
26. Anisowicz A, Messineo M, Lee SW, Sager R. An NF-kappa B-like transcription factor mediates IL-1/TNF-alpha induction of groin human fibroblasts. J Immunol 1991;147:520-7.
27. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M. Multiple control of interleukin-8 gene expression. J Leukoc Biol 2002;72:847-55.
28. Borgatti M, Boyd DD, Lampronti I, Bianchi N, Fabbri E, Saviano M et al. Decoy molecules based on PNA-DNA chimeras and targeting Sp1 transcription factors inhibit the activity of urokinase-type plasminogen activator receptor (uPAR) promoter. Oncol Res 2005;15:373-83.
29. Borgatti M, Lampronti I, Romanelli A, Pedone C, Saviano M, Bianchi N et al. Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites. J Biol Chem 2003;278:7500-9.
30. Friday BB, Mitchell PO, Kegley KM, Pavlath GK. Calcineurin initiates skeletal muscle differentiation by activating MEF2 and MyoD. Differentiation 2003;71:217-27.